Prevalence and Clinical Impact of SARS‐CoV‐2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID‐19 Pandemic

INTRODUCTION: In Europe, the SARS‐CoV‐2 pandemic had its first epicenter in Italy. Despite a significant mortality rate, the severity of most cases of COVID‐19 infection ranges from asymptomatic to mildly symptomatic, and silent infection affects a still‐unknown proportion of the general population....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncologist
Main Authors: Zambelli, Alberto, Chiudinelli, Lorenzo, Fotia, Vittoria, Negrini, Giorgia, Bosetti, Tommaso, Callegaro, Annapaola, Di Croce, Andrea, Caremoli, Elena Rota, Moro, Cecilia, Milesi, Laura, Poletti, Paola, Tasca, Cristina, Mandalà, Mario, Merelli, Barbara, Mosconi, Stefania, Arnoldi, Ermenegildo, Bettini, Anna, Bonomi, Lucia, Messina, Caterina, Ghilardi, Laura, Chirco, Alessandra, Maracino, Michela, Tondini, Carlo
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Inc. 2021
Assuntos:
Symptom Management and Supportive Care
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018331/
https://ncbi.nlm.nih.gov/pubmed/33355953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13654
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares